Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Expression of VEGF and semaphorin genes define subgroups of triple negative breast cancer.

Bender RJ, Mac Gabhann F.

PLoS One. 2013 May 8;8(5):e61788. doi: 10.1371/journal.pone.0061788. Print 2013.

PMID:
23667446
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
[PubMed - indexed for MEDLINE]
3.

Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.

Yotsumoto F, Tokunaga E, Oki E, Maehara Y, Yamada H, Nakajima K, Nam SO, Miyata K, Koyanagi M, Doi K, Shirasawa S, Kuroki M, Miyamoto S.

Mol Cancer Res. 2013 May;11(5):506-17. doi: 10.1158/1541-7786.MCR-12-0428. Epub 2013 Feb 26.

PMID:
23443317
[PubMed - indexed for MEDLINE]
Free Article
4.

Increased expression of biological markers as potential therapeutic targets in Saudi women with triple-negative breast cancer.

Sayed-Ahmed MM, Hafez MM, Al-Shabanah OA, Al-Rejaie SS, Aleisa AM, Al-Yahya AA, Alsheikh A, Al Diab AI, Al-Akeely MH.

Tumori. 2013 Jul-Aug;99(4):545-54. doi: 10.1700/1361.15109.

PMID:
24326846
[PubMed - indexed for MEDLINE]
5.

Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systems.

Mudvari P, Ohshiro K, Nair V, Horvath A, Kumar R.

PLoS One. 2013 Sep 23;8(9):e74993. doi: 10.1371/journal.pone.0074993. eCollection 2013.

PMID:
24086418
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.

Linderholm BK, Hellborg H, Johansson U, Elmberger G, Skoog L, Lehtiö J, Lewensohn R.

Ann Oncol. 2009 Oct;20(10):1639-46. doi: 10.1093/annonc/mdp062. Epub 2009 Jun 23.

PMID:
19549711
[PubMed - indexed for MEDLINE]
Free Article
7.

Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.

Lindner R, Sullivan C, Offor O, Lezon-Geyda K, Halligan K, Fischbach N, Shah M, Bossuyt V, Schulz V, Tuck DP, Harris LN.

PLoS One. 2013 Nov 18;8(11):e71915. doi: 10.1371/journal.pone.0071915. eCollection 2013.

PMID:
24260093
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

Karn T, Pusztai L, Holtrich U, Iwamoto T, Shiang CY, Schmidt M, Müller V, Solbach C, Gaetje R, Hanker L, Ahr A, Liedtke C, Ruckhäberle E, Kaufmann M, Rody A.

PLoS One. 2011;6(12):e28403. doi: 10.1371/journal.pone.0028403. Epub 2011 Dec 29.

PMID:
22220191
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer.

Yu KD, Zhu R, Zhan M, Rodriguez AA, Yang W, Wong S, Makris A, Lehmann BD, Chen X, Mayer I, Pietenpol JA, Shao ZM, Symmans WF, Chang JC.

Clin Cancer Res. 2013 May 15;19(10):2723-33. doi: 10.1158/1078-0432.CCR-12-2986. Epub 2013 Apr 2.

PMID:
23549873
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.

Król M, Pawłowski KM, Dolka I, Musielak O, Majchrzak K, Mucha J, Motyl T.

Vet Res Commun. 2011 Oct;35(7):409-23. doi: 10.1007/s11259-011-9489-3. Epub 2011 Jun 29.

PMID:
21713436
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression.

Zhou H, Binmadi NO, Yang YH, Proia P, Basile JR.

Angiogenesis. 2012 Sep;15(3):391-407. doi: 10.1007/s10456-012-9268-y. Epub 2012 Apr 3.

PMID:
22476930
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.

Kigel B, Varshavsky A, Kessler O, Neufeld G.

PLoS One. 2008 Sep 26;3(9):e3287. doi: 10.1371/journal.pone.0003287.

PMID:
18818766
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Brain-metastatic triple-negative breast cancer cells regain growth ability by altering gene expression patterns.

Choi YK, Woo SM, Cho SG, Moon HE, Yun YJ, Kim JW, Noh DY, Jang BH, Shin YC, Kim JH, Shin HD, Paek SH, Ko SG.

Cancer Genomics Proteomics. 2013 Nov-Dec;10(6):265-75.

PMID:
24336635
[PubMed - indexed for MEDLINE]
15.

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.

Karn T, Pusztai L, Ruckhäberle E, Liedtke C, Müller V, Schmidt M, Metzler D, Wang J, Coombes KR, Gätje R, Hanker L, Solbach C, Ahr A, Holtrich U, Rody A, Kaufmann M.

Eur J Cancer. 2012 Jan;48(1):12-23. doi: 10.1016/j.ejca.2011.06.025. Epub 2011 Jul 7.

PMID:
21741824
[PubMed - indexed for MEDLINE]
16.

Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis.

Komatsu M, Yoshimaru T, Matsuo T, Kiyotani K, Miyoshi Y, Tanahashi T, Rokutan K, Yamaguchi R, Saito A, Imoto S, Miyano S, Nakamura Y, Sasa M, Shimada M, Katagiri T.

Int J Oncol. 2013 Feb;42(2):478-506. doi: 10.3892/ijo.2012.1744. Epub 2012 Dec 18.

PMID:
23254957
[PubMed - indexed for MEDLINE]
17.

Triple negative breast cancers have a reduced expression of DNA repair genes.

Ribeiro E, Ganzinelli M, Andreis D, Bertoni R, Giardini R, Fox SB, Broggini M, Bottini A, Zanoni V, Bazzola L, Foroni C, Generali D, Damia G.

PLoS One. 2013 Jun 25;8(6):e66243. doi: 10.1371/journal.pone.0066243. Print 2013.

PMID:
23825533
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells.

Yoshikawa Y, Sato A, Tsujimura T, Morinaga T, Fukuoka K, Yamada S, Murakami A, Kondo N, Matsumoto S, Okumura Y, Tanaka F, Hasegawa S, Hashimoto-Tamaoki T, Nakano T.

Int J Oncol. 2011 Dec;39(6):1365-74. doi: 10.3892/ijo.2011.1158. Epub 2011 Aug 12.

PMID:
21842119
[PubMed - indexed for MEDLINE]
19.

Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.

Radovich M, Clare SE, Atale R, Pardo I, Hancock BA, Solzak JP, Kassem N, Mathieson T, Storniolo AM, Rufenbarger C, Lillemoe HA, Blosser RJ, Choi MR, Sauder CA, Doxey D, Henry JE, Hilligoss EE, Sakarya O, Hyland FC, Hickenbotham M, Zhu J, Glasscock J, Badve S, Ivan M, Liu Y, Sledge GW, Schneider BP.

Breast Cancer Res Treat. 2014 Jan;143(1):57-68. doi: 10.1007/s10549-013-2780-y. Epub 2013 Nov 29.

PMID:
24292813
[PubMed - indexed for MEDLINE]
20.

A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients.

Lee U, Frankenberger C, Yun J, Bevilacqua E, Caldas C, Chin SF, Rueda OM, Reinitz J, Rosner MR.

PLoS One. 2013 Dec 11;8(12):e82125. doi: 10.1371/journal.pone.0082125. eCollection 2013.

PMID:
24349199
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk